Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Guy H. M. Jerusalem
Based on 58 articles published since 2009
(Why 58 articles?)
||||
Expertise Level
The expertise of Guy H. M. Jerusalem ranks in the
  • Top 0.055%
  • ... of 287,191 published authors worldwide on Breast Neoplasms
  • ... from 2009 through 2019
  • ... based on contributions to 58 articles on the topic.
Graphical view (beta)
Get your prestigious
World Expert badge
similar to this:
 
Aliases Jerusalem, Guy H M   ·   Jerusalem, G   ·   Jérusalem, Guy   ·   Jerusalem, Guy
Work Locations
Details
Most likely:    Universite de Liege      
2019
  • Department of Medical Oncology, Centre Hospitalier Universitaire du Sart-Tilman, University of Liege, Liège, Belgium. · GIGA Cardiovascular Sciences, Department of Cardiology, Centre Hospitalier Universitaire du Sart-Tilman, University of Liege, Liège, Belgium. · Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Korea. · Pubmed 31165940
  • AZ Glorieux, Ronse, Belgium and Gent University Hospital, Ghent, Belgium. · Gent University Hospital, De Pintelaan 185, 9000, Ghent, Belgium. · Department of Medical Oncology, Imelda Hospital, Bonheiden, Belgium. · CHU Sart Tilman Liège and University of Liège, Liège, Belgium. · OncoLogX, Antwerp, Belgium. · Amgen, Brussels, Belgium. · Gent University Hospital, De Pintelaan 185, 9000, Ghent, Belgium. · Pubmed 30099601
2018
  • Laboratory of Human Genetics, GIGA-Institute, University of Liège, 4500 Liège, Belgium. · Laboratory of Human Genetics, GIGA-Institute, University of Liège, 4500 Liège, Belgium. · Laboratory of Human Genetics, GIGA-Institute, University of Liège, 4500 Liège, Belgium. · Center of Genetics, University Hospital (CHU), 4500 Liège, Belgium. · Laboratory of Human Genetics, GIGA-Institute, University of Liège, 4500 Liège, Belgium. · Department of Medical Oncology, University Hospital (CHU), 4500 Liège, Belgium. · Laboratory of Medical Oncology, GIGA-Institute, University of Liège, 4500 Liège, Belgium. · Department of Medical Oncology, University Hospital (CHU), 4500 Liège, Belgium. · Laboratory of Medical Oncology, GIGA-Institute, University of Liège, 4500 Liège, Belgium. · Pubmed 29301303
  • Northern Centre for Cancer Care, Newcastle University, Newcastle upon Tyne, UK. · Department of Medical Oncology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands. · University Medical Center Utrecht, University of Utrecht, Utrecht, The Netherlands. · Universitair Ziekenhuis Leuven, Leuven, Belgium. · The Royal Marsden and Institute of Cancer Research, Sutton, UK. · Universitair Ziekenhuis Antwerpen, Antwerp, Belgium. · Herlev Hospital, University of Copenhagen, Herlev, Denmark. · Department of Medical Oncology, Oncologisch Centrum, Universitair Ziekenhuis Brussel, Brussels, Belgium. · Universitair Ziekenhuis Gent, Ghent, Belgium. · CHU Sart-Tilman Liege, Liege University, Liege, Belgium. · Department of Medical Oncology, Institut Bergonié, Comprehensive Cancer Centre Bordeaux, Bordeaux, France. · King's College London, Guy's Hospital, London, UK. · Campus Sint-Augustinus, GZA Ziekenhuizen, Antwerp, Belgium. · AstraZeneca, Gaithersburg, MD, USA. · AstraZeneca, Macclesfield, UK. · AstraZeneca, Cambridge, UK. · The Christie NHS Foundation Trust, University of Manchester, Manchester, UK. · Pubmed 30324586
  • Department of Sport and Rehabilitation Science, Liège University, Liège, Belgium; Department of Physical and Rehabilitation Medicine, Liège University Hospital, Liège, Belgium. Electronic address: · Department of Public Health, Epidemiology and Health Economics, Liège University, Liège, Belgium. · Division of Medical Oncology, Liège University, Liège University Hospital, Liège, Belgium. · Department of Radiotherapy, Liège University, Liège University Hospital, Liège, Belgium. · Department of Sport and Rehabilitation Science, Liège University, Liège, Belgium; Department of Physical and Rehabilitation Medicine, Liège University Hospital, Liège, Belgium. · Department of Sport and Rehabilitation Science, Liège University, Liège, Belgium. · Clinical Hematology Service, Oncology Centre, Liège University Hospital, Liège, Belgium. · Pubmed 29880408
  • CHU Sart Tilman Liege and Liege University, Liege, Belgium. · Royal Melbourne Hospital, Victoria, Australia. · Jonsson Comprehensive Cancer Center, University of California, Los Angeles. · Sarah Cannon Research Institute, Nashville, Tennessee. · Tennessee Oncology, PLLC, Nashville, Tennessee. · Russian Cancer Research Center, Moscow, Russia. · Copenhagen University Hospital, Copenhagen, Denmark. · Rainier Hematology-Oncology, Northwest Medical Specialties, Tacoma, Washington. · Cerrahpaşa School of Medicine, Istanbul University, Istanbul, Turkey. · Uzsoki Teaching Hospital, Budapest, Hungary. · Institute of Clinical Research, Odense University Hospital, University of Southern Denmark, Odense, Denmark. · Novartis Pharmaceuticals Corporation, East Hanover, New Jersey. · Novartis Pharma AG, Basel, Switzerland. · Novartis Pharma SAS, Paris, France. · Pubmed 29862411
  • Dennis J. Slamon, University of California Los Angeles Medical Center, Santa Monica, CA · Patrick Neven, Multidisciplinary Breast Centre, Universitair Ziekenhuis, Leuven · Guy Jerusalem, Centre Hospitalier Universitaire de Liege and Liege University, Liège, Belgium · Stephen Chia, British Columbia Cancer Agency, Vancouver, British Columbia, Canada · Peter A. Fasching, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen · Arnd Nusch, Practice for Hematology and Internal Oncology, Velbert, Germany · Michelino De Laurentiis, Istituto Nazionale Tumori "Fondazione G. Pascale," Naples · Giulia Val Bianchi, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale dei Tumori, Milan, Italy · Seock-Ah Im, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea · Katarina Petrakova, Masaryk Memorial Cancer Institute, Brno, Czech Republic · Francisco J. Esteva, New York University Langone Health, New York, NY · Miguel Martín, Instituto de Investigacion Sanitaria Gregorio Marañon, Centro de Investigación Biomédica en Red de Cáncer, Grupo Español de Investigación en Cáncer de Mama, Universidad Complutense, Madrid · Luis De la Cruz-Merino, Hospital Universitario Virgen Macarena, Seville, Spain · Gabe S. Sonke, Netherlands Cancer Institute/Borstkanker Onderzoek Groep Study Center, Amsterdam, the Netherlands · J. Thaddeus Beck, Highlands Oncology Group, Fayetteville, AR · Xavier Pivot, Institut Régional du Cancer, Strasbourg, France · Gena Vidam, Karen Rodriguez Lorenc, Michelle Miller, and Tetiana Taran, Novartis Pharmaceuticals, East Hanover, NJ · and Yingbo Wang, Novartis Pharma, Basel, Switzerland. · Pubmed 29860922
  • Sandro Pitigliani Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Via Suor Niccolina 20, Prato 59100, Italy. Electronic address: · CHU Sart Tilman Liège and Liège University, Avenue de L'Hôpital 1, 4000 Liège, Belgium. Electronic address: · Instituto Nacional del Cáncer, Avda Profesor Zañartu 1010, Independencia, Santiago, Región Metropolitana, Chile. Electronic address: · University of Antwerp, Prinsstraat 13, 2000 Antwerpen, Belgium. Electronic address: · University of Kansas Cancer Center, 1000 E 101st Terrace, Kansas City, MO 64131, USA. Electronic address: · Sandro Pitigliani Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Via Suor Niccolina 20, Prato 59100, Italy. Electronic address: · AstraZeneca, da Vinci Building, Melbourn Science Park, Melbourn, Royston, Herts, SG8 6HB, UK. Electronic address: · Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, CiberOnc, GEICAM, Madrid 28007, Spain. Electronic address: · Pubmed 29324303
  • Division of Medical Oncology, E.O. Ospedali Galliera, Genova, Italy. · IBCSG Statistical Center, Boston, USA. · Frontier Science and Technology Research Foundation, Boston, USA. · Breast Center, Kantonsspital St. Gallen, St. Gallen. · SAKK, Bern, Switzerland. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Department of Medical Oncology, St. James Hospital, Dublin, Ireland. · FMH Medical Oncology, Chur, Switzerland. · Department of Medical Oncology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Department of Medical Oncology, Ramon y Cajal University Hospital, Barcelona, Spain. · Breast Cancer & Melanoma Group, Hospital Universitari Vall D'Hebron, Barcelona, Spain. · Centre for Systems Medicine, Beaumont Hospital, Dublin, Ireland. · Clinical Trials, Ireland. · Oncology Research Group, Hospital Universitari Sant Joan De Reus, Tarragona, Spain. · IBCSG Coordinating Center, Bern, Switzerland. · Bern University Hospital, Inselspital, Bern, Switzerland. · Medical Oncology, Hospital Universitari Arnau De Vilanova De Lleida, Lleida, Spain. · Breast Unit, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland. · Onco-Hematology, CHPLT Verviers, Verviers, Belgium. · Institute of Oncology, Ljubljana, Slovenia. · IBCSG Statistical Center, Dana-Farber Cancer Institute, Boston, USA. · Department of Medicine, Harvard Medical School, Boston, USA. · Medical Oncology, CHU Sart Tilman, Liege, Belgium. · Pubmed 29228091
  • Breast Cancer Unit, Institut Gustave Roussy, 114 Rue Edouard-Vaillant, 94800, Villejuif, France. · Macerata Hospital, Macerata, Italy. · Saint Luke's Health System, Kansas City, MO, USA. · Onkologikoa Foundation, San Sebastian, Spain. · Catalan Institute of Oncology, Barcelona, Spain. · Ospedale Oncologico, Cagliari, Italy. · University of Birmingham and University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK. · University of Oxford and Oxford University Hospitals NHS Trust, Oxford, UK. · Centre Léon Bérard et Inserm U1052, Lyon, France. · Nottingham University Hospitals NHS Trust, Nottingham, UK. · Moffitt Cancer Center, Tampa, FL, USA. · CHU Sart Tilman Liège and University of Liège, Liège, Belgium. · Novartis Pharma AG, Basel, Switzerland. · Novartis Institutes for BioMedical Research, Cambridge, MA, USA. · Novartis Pharmaceuticals Corporation, Rueil-Malmaison, France. · Syros Pharmaceuticals, Watertown, MA, USA. · Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Pubmed 29198055
  • International Breast Cancer Study Group, Milan, Italy; Division of Medical Senology, Milan, Italy. Electronic address: · International Breast Cancer Study Group Statistical Center, Boston, MA, USA; Dana-Farber Cancer Institute, Boston, MA, USA. · International Breast Cancer Study Group and Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. · International Breast Cancer Study Group, Australia and New Zealand Breast Cancer Trials Group, and Box Hill and Maroondah Hospitals, Monash University, Melbourne, VIC, Australia. · International Breast Cancer Study Group and Lucerne Canton Hospital, Lucerne, Switzerland. · International Breast Cancer Study Group, Centre Hospitalier Universitaire de Liège, Liège University, Liège, Belgium. · International Breast Cancer Study Group and Multidisciplinary Breast Center, University Hospitals, Katholieke Universiteit Leuven, Leuven, Belgium. · International Breast Cancer Study Group and National Institute of Oncology, Budapest, Hungary. · International Breast Cancer Study Group and Centre Hospitalier Chrétien Clinique St Joseph, Liège, Belgium. · International Breast Cancer Study Group and ASST Spedali Civili di Brescia, Brescia, Italy. · Danish Breast Cancer Group and Rigshospitalet, Copenhagen, Denmark. · Scottish Cancer Trials Breast Group and The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · German Breast Group, Neu-Isenburg, Germany. · SOLTI Group and Fundación Instituto Valenciano de Oncologia, Valencia, Spain. · Japan Breast Cancer Research Group and Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan. · Austrian Breast & Colorectal Cancer Study Group and Department of Obstetrics and Gynecology, Medical University Innsbruck, Innsbruck, Austria. · Chilean Cooperative Group for Oncologic Research, Providencia, Santiago, Chile. · Cancer Trials Ireland and Cork University Hospital, Cork, Ireland. · International Breast Cancer Study Group and Centro di Riferimento Oncologico di Aviano, Aviano, Italy. · Medical Oncology Clinic, Institute Jules Bordet, Brussels, Belgium. · Swiss Group for Clinical Cancer Research, International Breast Cancer Study Group, and Breast Center St Gallen, St Gallen, Switzerland. · Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. · International Breast Cancer Study Group Coordinating Center, Bern, Switzerland. · International Breast Cancer Study Group Coordinating Center, Bern, Switzerland; Bern University Hospital, Inselspital, Bern, Switzerland. · European Institute of Oncology, Milan, Italy; International Breast Cancer Study Group Central Pathology Office and University of Milan, Milan, Italy. · International Breast Cancer Study Group, Inselspital, Bern, Switzerland; Bern University Hospital, Inselspital, Bern, Switzerland. · International Breast Cancer Study Group Statistical Center, Boston, MA, USA; Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Harvard T H Chan School of Public Health, Boston, MA, USA; Frontier Science & Technology Research Foundation, Boston, MA, USA. · International Breast Cancer Study Group and University of Sydney, Sydney, NSW, Australia. · International Breast Cancer Study Group and Hospital of Prato-AUSL Toscana Centro, Istituto Toscano Tumori, Prato, Italy. · International Breast Cancer Study Group Statistical Center, Boston, MA, USA; Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. · International Breast Cancer Study Group, Milan, Italy; European Institute of Oncology, Milan, Italy. · Pubmed 29158011
  • Sint Augustinus-University of Antwerp, Antwerp, Belgium. · Semmelweis University, Budapest, Hungary. · CHU Sart Tilman Liege and Liege University, Liege, Belgium. · University Cancer & Blood Center, LLC, Athens, GA, USA. · Sarah Cannon Research Institute, London, UK. · University College London Cancer Institute, London, UK. · University of Alabama, Birmingham, AL, USA. · Center for Cancer and Blood Disorders, Bethesda, MD, USA. · University of Miami Miller School of Medicine, Miami, FL, USA. · Cooper Hospital University Medical Center, Camden, NJ, USA. · Nemocnice Horovice, Onkologicke Oddelení, Horovice, Czech Republic. · The John Hopkins University School of Medicine, Baltimore, MD, USA. · Michigan State University, East Lansing, MI, USA. · Greenville Hospital System, Greenville, SC, USA. · Metairie Oncologist LLC, Metairie, LA, USA. · Merck KGaA, Darmstadt, Germany. · EMD Serono, Billerica, MA, USA. · Sarah Cannon Research Institute, Nashville, TN, USA. · Pubmed 29063313
  • Public Health Department and Sensation and Perception Research Group, GIGA-Consciousness, University of Liège, Liège, Belgium. · Algology-Palliative Care Department, CHU Liège, and Sensation and Perception Research Group, GIGA-Consciousness, University of Liège, Liège, Belgium. · GIGA-Consciousness, Coma Science Group & Neurology Department, University and CHU of Liège, Liège, Belgium. · Medical Oncology Department, CHU Liège and University of Liège, Liège, Belgium. · Public Health Department and Sensation and Perception Research Group, GIGA-Consciousness, University of Liège, Liège, Belgium. · Pubmed 30442120
  • Department of Medical Oncology, University Hospital (CHU) and University of Liège, Liège, Belgium. · Laboratory of Human Genetics, GIGA Research, University Hospital (CHU) and University of Liège, Liège, Belgium. · GIGA Cardiovascular Sciences, Department of Cardiology, Heart Valve Clinic, University Hospital (CHU) and University of Liège, Liège, Belgium. · Gruppo Villa Maria Care and Research, Anthea Hospital, Bari, Italy. · Department of Medical Oncology, University Hospital (CHU) and University of Liège, Liège, Belgium. · Pubmed 29378531
2017
  • Health Psychology Department, University of Liege, Liege 4000, Belgium. · Public Health Department, University of Liege, Liege 4000, Belgium. · Medical Oncology Department, CHU Liege, Liege 4000, Belgium. · Radiation Oncology Department, CHU Liege, University of Liege, Liege 4000, Belgium. · Psychology Department, University of Quebec at Montreal, Montreal, QC H2L 2C4, Canada. · Algology-Palliative Care Department, CHU Liege, University of Liege, Liege 4000, Belgium. · Pubmed 28926526
  • a University of Liege , Liege , Wallonia , Belgium. · b University of Quebec at Montreal , Montreal , Quebec , Canada. · Pubmed 28230462
  • University of Liège, GIGA-Research, Laboratory of Human Genetics, Liege, Belgium. · University Hospital (CHU), Department of Medical Oncology, Liege, Belgium. · University Hospital (CHU), Center of Genetics, Liege, Belgium. · University of Liège, GIGA-Genomics Platform, Liege, Belgium. · Clinique Saint-Vincent (CHC), Department of Pathology, Liege, Belgium. · University of Liège, GIGA-Research, Laboratory of Human Genetics, Liege, Belgium. · University Hospital (CHU), Department of Medical Oncology, Liege, Belgium. · Pubmed 29234122
  • Psychology of Aging Unit, Department of Psychology, University of Liège (ULg), Traverse des Architectes (B63c), 4000, Liege, BE, Belgium. · INSERM U12919 Bordeaux Population Health, University of Bordeaux, Bordeaux, France. · Psychology of Aging Unit, Department of Psychology, University of Liège (ULg), Traverse des Architectes (B63c), 4000, Liege, BE, Belgium. · Laboratory of Medical Oncology, University of Liège, Liège, Belgium. · Department of Medical Oncology, CHU Sart-Tilman Liège, Liège, Belgium. · Department of General Practice, KU Leuven, Leuven, Belgium. · CAPHRI Research School, Maastricht University, Maastricht, The Netherlands. · Pubmed 28865449
  • Department of Sport and Rehabilitation Science, Liège University, Liège, Belgium - · Department of Physical Medicine, Liège University Hospital, Liège, Belgium - · Department of Sport and Rehabilitation Science, Liège University, Liège, Belgium. · Department of Physical Medicine, Liège University Hospital, Liège, Belgium. · Department of Radiotherapy, Liège University, Liège University Hospital, Liège, Belgium. · Clinical Hematology Service, Oncology Center, Liège University Hospital, Liège, Belgium. · Department of Public Health, Epidemiology and Health Economics, Liège University, Liège, Belgium. · Division of Medical Oncology, Liège University, Liège University Hospital, Liège, Belgium. · Department of Senology, Liège University Hospital, Liège, Belgium. · Pubmed 28322035
  • Laboratory of Tumor and Developmental Biology, Groupe Interdisciplinaire de Génoprotéomique Appliqué-Cancer (GIGA-Cancer), University of Liège, Liège 4000, Belgium. · Department of Medical Oncology, University Hospital of Liège (CHU), Liège 4000, Belgium. · Faculty of Medicine, University of Liège, Liège 4000, Belgium. · Laboratory of Experimental Pathology, GIGA-Cancer, University of Liège, Liège 4000, Belgium. · Biobank (Biothèque Universitaire de Liège), University of Liège, Liège 4000, Belgium. · Department of Biostatistics, University of Liège, 4000 Liège, Belgium. · Pubmed 28196064
  • Psychology of Aging Unit, University of Liège, Liège, Belgium. Electronic address: · Psychology of Aging Unit, University of Liège, Liège, Belgium. · Laboratory of medical oncology, University of Liège, Liège, Belgium; Department of Medical Oncology, CHU Sart-Tilman Liège, Liège, Belgium. · Department of Social Psychology, University of Liège, Liège, Belgium. · Department of General Practice, KU Leuven, Leuven, Belgium; CAPHRI Research School, Maastricht University, Maastricht, The Netherlands. · Pubmed 27659547
2016
  • Department of Medical Oncology, CHU Sart Tilman Liege and Liege University, Domaine Universitaire du Sart Tilman, Liege, Belgium · Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy. · Medical Oncology Department, Breast Cancer Unit, University Hospital 12 de Octubre, Madrid, Spain. · Instituto de Investigación Sanitaria Gregorio Marañón, Univesidad Complutense, Madrid, Spain. · Department of Medical Oncology, GROW, Maastricht University Medical Centre, Maastricht, The Netherlands. · KULeuven (University of Leuven), Department of Oncology, Multidisciplinary Breast Center, University Hospitals Leuven, Belgium. · Medical Oncology Unit of Fundacion Instituto Valenciano De Oncologia, Valencia, Spain. · UO Oncologia Medica I, Azienda Ospedaliera Universitaria Pisana, Santa Chiara Hospital, Pisa, Italy. · Unit of Investigative Clinical Oncology (INCO), Fondazione del Piemonte per l'Oncologia, Institute of Candiolo Cancer Center (IRCCs), Candiolo, Torino, Italy. · Department of Medical, Surgery and Health Sciences, University of Trieste, Trieste, Italy. · Breast Unit, Azienda Ospedaliera Spedali Civili, Brescia, Italy. · Medical Oncology and Clinical Pharmacology, National Institute of Oncology, Budapest, Hungary. · Narodny Onkologicky Ustav Klenova 1, Bratislava, Slovakia. · Department of Oncology, Oslo University Hospital, Oslo, Norway K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. · Novartis Farma S.p.A., Origgio, VA, Italy. · Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy Medical Oncology 2, Istituto Oncologico Veneto, Padova, Italy. · Pubmed 27358383
  • Fabrice André, Institut Gustav Roussy, INSERM Unit U981, Université Paris Sud, Villejuif, France · Sara Hurvitz and Dennis Slamon, University of California, Los Angeles, Los Angeles, CA · Angelica Fasolo, San Raffaele Scientific Institute, Milan, Italy · Ling-Ming Tseng, National Yang Ming University, Taipei, Taiwan · Guy Jerusalem, University of Liège, Liege, Belgium · Sharon Wilks, Cancer Care Center of South Texas, San Antonio, TX · Ruth O'Regan, University of Wisconsin Carbone Cancer Center, Madison, WI · Claudine Isaacs, Georgetown University, Washington DC · Masakazu Toi, Kyoto University, Sakyo-ku, Kyoto, Japan · Howard Burris, Sarah Cannon Research Institute, Nashville, TN · Wei He, Douglas Robinson, and Markus Riester, Novartis Institutes for BioMedical Research, Cambridge, MA · and Tetiana Taran and David Chen, Novartis Pharmaceuticals Corporation, East Hanover, NJ. · Pubmed 27091708
  • GIGA-Cancer, Laboratory of Tumor and Development Biology, University of Liège, Liège, Belgium. · CHU, Department of Medical Oncology, University of Liège, Liège, Belgium. · GIGA-Cardiovascular Sciences, Laboratory of Thrombosis and Hemostasis, University of Liège, Liège, Belgium. · Unit of Molecular and Cellular Oncology Lab, Inflammation Research Center, VIB, Ghent, Belgium. Department of Biomedical Molecular Biology, Cancer Research Institute Ghent (CRIG), Ghent University, Ghent, Belgium. · Institute of Health and Biomedical Innovation and School of Biomedical Sciences Translational Research Institute, Queensland University of Technology, Brisbane, Australia. · GIGA-Neurosciences, Unit of Cell and Tissue Biology, University of Liège, Liège, Belgium. · Australian Prostate Cancer Research Centre - Queensland, Institute of Health and Biomedical Innovation, School of Biomedical Sciences, Queensland University of Technology, Princess Alexandra Hospital, Translational Research Institute, Brisbane, Australia. · INSERM UMR-S 903, CHU, Biopathology Laboratory, University of Reims, Reims, France. · GIGA-Cancer, Laboratory of Tumor and Development Biology, University of Liège, Liège, Belgium. · Pubmed 27221703
  • University Hospital (CHU), Department of Medical Oncology, Liège, Belgium. · University of Liège, GIGA-Research, Laboratory of Human Genetics, Liège, Belgium. · University of Liège, GIGA-Research, Laboratory of Molecular Angiogenesis, Liège, Belgium. · University of Liège, GIGA-Research, Department of EE and CS, Liège, Belgium. · University Hospital (CHU), Department of Gynecology, Liège, Belgium. · University Hospital (CHU), Department of Senology, Liège, Belgium. · Clinique Saint-Vincent (CHC), Department of Pathology, Liège, Belgium. · Pubmed 26734993
  • Psychology of Aging Unit,University of Liège (B63C),Liège,Belgium. · Laboratory of Medical Oncology,University of Liège,Liège,Belgium. · Department of Nursing,CHU Sart-Tilman Liège,Liège,Belgium. · Pubmed 26669734
2015
  • Medical Oncology, CHU Sart Tilman Liege & Liege University, Domaine Universitaire du Sart Tilman, B35, 4000 Liege, Belgium. · University of Liège Hospital, GIGA Cardiovascular Sciences, Cardio-Oncology Clinic Unit, CHU Sart Tilman Liege & Liege University, Domaine Universitaire du Sart Tilman, B35, 4000 Liege, Belgium. · Pubmed 26344798
  • Medical Oncology CHU Sart Tilman Liege & Liege University, Domaine Universitaire du Sart Tilman, B35, 4000 Liege, Belgium. · Medical Oncology CHU Sart Tilman Liege, Domaine Universitaire du Sart Tilman, B35, 4000 Liege, Belgium. · Pubmed 26075446
  • University of Liège Hospital, GIGA Cardiovascular Science, Heart Valve Clinic, Imaging Cardiology, Belgium and GVM Care and Research, E.S. Health Science Foundation, Lugo (RA), Italy · Department of Innovative Clinical Trials, University Medical Center Göttingen (UMG), Göttingen, Germany. · Cardiologie, CHU Rennes and LTSI-INSERM U 1099, Université Rennes 1, Rennes, France. · Department of Cardiology, Oslo University Hospital, Rikshospitalet and University of Oslo, Oslo, Norway Centre of Cardiological Innovation, Oslo, Norway. · University of Medicine and Pharmacy 'Carol Davila'-Euroecolab, 'Prof. Dr C. C. Iliescu' Institute of Cardiovascular Diseases, Bucharest, Romania. · Heart Failure Unit, Department of Cardiology, University Hospital 'Attikon', Athens, Greece. · Aix-Marseille Université, Marseille 13284, France Department of Cardiology, La Timone Hospital, 13005 Marseille, France. · ANMCO Research Center, Florence, Italy EORP Team, European Society of Cardiology, Sophia Antipolis, France. · Medical Oncology, CHU Sart Tilman Liege and Liege University, Liege, Belgium. · Department of Advanced Biomedical Sciences, Federico II University Hospital, Naples, Italy. · Pubmed 25744342
  • Centre Hospitalier Universitaire du Sart Tilman Liège and Liège University, Domaine Universitaire du Sart Tilman, B35, 4000 Liège, Belgium. Electronic address: · Centre de Recherche en Cancérologie de Lyon, Inserm U1052 CNRS 5286, Centre Léon Bérard, 28 rue Laënnec, 69373 LYON cedex 08, Lyon, France. Electronic address: · PUCRS School of Medicine, Padre Chagas 66, 203, Porto Alegre, RS 90 570 080, Brazil. Electronic address: · University Hospitals Leuven, Leuven, Belgium. Electronic address: · Hospital of Prato, Istituto Toscani Tumori, Prato, Italy. Electronic address: · Women's Hospital, University of Ulm, Prittwitzstr. 43, D-89075 Ulm, Germany. Electronic address: · Royal Melbourne Hospital, Grattan St., Parkville, Melbourne 3050, Australia. Electronic address: · Pubmed 25575443
  • Institut Curie, Paris, France. Electronic address: · University Hospital Leuven, Leuven, Belgium. Electronic address: · Medical University of Gdańsk, Gdańsk, Poland. Electronic address: · General Hospital Sint-Augustinus, Antwerp, Belgium. Electronic address: · Centre Léon Bérard, Lyon, France. Electronic address: · Helsinki University Central Hospital, Helsinki, Finland. Electronic address: · UCLA School of Medicine, Los Angeles, CA, USA. Electronic address: · Institut Paoli-Calmettes, Marseilles, France. Electronic address: · C.R.L.C. Val D'Aurelle, Montpellier, France. Electronic address: · Levine Cancer Institute, Charlotte, NC, USA. Electronic address: · CHU Sart Tilman, Liege, Belgium. Electronic address: · Kidwai Memorial Institute of Oncology, Bangalore, India. Electronic address: · Institut Claudius Régaud, Toulouse, France. Electronic address: · Complejo Hospitalario de Jaén, Jaén, Spain. Electronic address: · European Health Centre Otwock, Warszawa, Poland. Electronic address: · Corporació Sanitària Parc Taulí, Sabadell, Spain. Electronic address: · Amgen Inc., Thousand Oaks, CA, USA. Electronic address: · Amgen Inc., Thousand Oaks, CA, USA. Electronic address: · Amgen Inc., Thousand Oaks, CA, USA. Electronic address: · UCLA School of Medicine, Los Angeles, CA, USA. Electronic address: · Pubmed 25747197
  • Department of Medical Oncology, Institut Bergonié Comprehensive Cancer Centre, Université de Bordeaux, INSERM U916, Bordeaux · Department of Medical Oncology, Centre Val D'Aurelle-Paul Lamarque, Montpellier. · Department of Medical Oncology, Gustave Roussy, Villejuif. · Department of Medical Oncology, Centre Henri Becquerel, Rouen. · Department of Medical Oncology, Centre Hospitalier Universitaire, Limoges, France. · Department of Oncology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland. · Department of Medical Oncology, Institute of Oncology, Ljubljana, Ljubljana University Clinic, Golnik, Slovenia. · Department of Medical Oncology, Centre Paul Strauss, Strasbourg, France. · Gyneco-Oncology Unit, Hôpitaux Universitaires de Genève (HUG), Geneva, Switzerland. · Department of Medical Oncology, Institut Bergonié Comprehensive Cancer Centre, Université de Bordeaux, INSERM U916, Bordeaux. · Department of Medical Oncology, Hôpital St Elisabeth, Namur. · Department of Medical Oncology, Centre Hospitalier Universitaire (Sart Tilman), Liege, Belgium. · Medical Oncology and Clinical Research Unit, Ensemble Hospitalier de L'Institut Curie, Hôpital René Huguenin, St-Cloud. · Department of Medical Oncology, Centre Léon Bérard, Lyon, France. · Department of Statistics, European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium. · Edinburgh Breast Unit and Edinburgh University Cancer Research Centre, Western General Hospital, Edinburgh, UK. · Pubmed 25467016
  • a Department of Plastic and Maxillo-facial Surgery, University Hospital , Belgique. · b Department of Abdominal, Breast and Endocrine Surgery and Transplantation , Belgique. · c Department of Senology , Belgique. · d Department of Anatomo-pathology , Belgique. · e Department of Biostatistics, SIME ; Belgique . · f Department of Radiotherapy , Belgique. · g Department of Medical Oncology , University Hospital, C.H.U. de Liege, Domaine Universitaire du Sart-Tilman - B. 35 , 4000 Liege, Belgique. · Pubmed 27384894
  • Centre Hospitalier Universitaire Sart Tilman Liège and Liège University, Domaine Universitaire du Sart Tilman, B35, 4000, Liège, Belgium. · University Hospitals Leuven, Herestraat 49, box 7003, B-3000, Leuven, Belgium. · Navigant Consulting, Inc, Woolgate Exchange, 25 Basinghall Street, EC2V 5HA, London, UK. · Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, NJ, 07936-1080, USA. · Navigant Consulting, Inc, Woolgate Exchange, 25 Basinghall Street, EC2V 5HA, London, UK. · Novartis Farma S.p.A., Largo Umberto Boccioni 1, I-21040, Origgio, VA, Italy. · Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, NJ, 07936-1080, USA. · Wellmera AG, Basel, Switzerland. · Institut Gustave Roussy, 39 Rue C. Desmoulins, 94805, Villejuif, France. · Pubmed 26498283
  • Human Genetics Unit, GIGA-Cancer Research, University of Liège, Liège, Belgium. · Human Genetics Unit, GIGA-Cancer Research, University of Liège, Liège, Belgium. · Human Genetics Unit, GIGA-Cancer Research, University of Liège, Liège, Belgium. · Human Genetics Unit, GIGA-Cancer Research, University of Liège, Liège, Belgium. · Human Genetics Unit, GIGA-Cancer Research, University of Liège, Liège, Belgium. · Medical Oncology Department, University of Liège and CHU de Liège, Liège, Belgium. · GIGA-bioinformatics platform, University of Liège, Liège, Belgium. · Human Genetics Unit, GIGA-Cancer Research, University of Liège, Liège, Belgium. · Medical Oncology Department, University of Liège and CHU de Liège, Liège, Belgium. · Center of Genetics, CHU de Liège, Liège, Belgium. · Medical Oncology Department, University of Liège and CHU de Liège, Liège, Belgium. · Medical Oncology Department, University of Liège and CHU de Liège, Liège, Belgium. · Human Genetics Unit, GIGA-Cancer Research, University of Liège, Liège, Belgium. · Center of Genetics, CHU de Liège, Liège, Belgium. · Pubmed 26490435
  • Metastasis Research Laboratory, GIGA-Cancer, University of Liège, Liège, Belgium. · Department of Pathology, University Hospital Liège, University of Liège, Liège, Belgium. · Biotheque, University of Liège, Liège, Belgium. · Animal Facility, GIGA-Cardiovascular Sciences, University of Liège, Liège, Belgium. · Metastasis Research Laboratory, GIGA-Cancer, University of Liège, Liège, Belgium; Department of Pharmacy and Health and Nutritional Sciences, University of Calabria, Arcavacata di Rende, Cosenza, Italy. · GIGA-Viral Vectors Platform, University of Liège, Liège, Belgium. · Department of Senology, University Hospital Liège, University of Liège, Liège, Belgium. · Department of Abdominal Surgery, University of Liège, Liège, Belgium. · Department of Medical Oncology, University Hospital Liège, University of Liège, Liège, Belgium. · Pubmed 26327350
  • U.O. di Patologia Mammaria-Breast Cancer Unit, U.S. Terapia Molecolare e Farmacogenomica, AO-Istituti Ospitalieri di Cremona, Viale Concordia 1, 26100, Cremona, Italy. · Centre for Research on Health and Social Care Management (CeRGAS), Bocconi University, Via Roentgen 1, Milan, Italy. · Yale Cancer Center, Yale School of Medicine, New Haven, CT, United States. · Translational Breast Cancer Genomics and Therapeutics Lab, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Centre Hospitalier Universitaire du Sart Tilman Liege and Liege University, Liège, Belgium. · U.O. di Patologia Mammaria-Breast Cancer Unit, U.S. Terapia Molecolare e Farmacogenomica, AO-Istituti Ospitalieri di Cremona, Viale Concordia 1, 26100, Cremona, Italy. · Department of Policy Analysis and Public Management, Bocconi University, Via Roentgen 1, Milan, Italy. · Pubmed 26044370
  • University of Liège, GIGA-Cancer Research, Human Genetics Unit, Liège, Belgium. · University of Liège, GIGA-Cancer Research, Human Genetics Unit, Liège, Belgium. · Division of Medical Oncology, Liège University and CHU Sart Tilman Liège, Liège, Belgium. · Human Genetics Department, Liège University Hospital, Liège, Belgium. · University of Liège, GIGA-Cancer Research, Human Genetics Unit, Liège, Belgium. · Division of Medical Oncology, Liège University and CHU Sart Tilman Liège, Liège, Belgium. · Division of Medical Oncology, Liège University and CHU Sart Tilman Liège, Liège, Belgium. · University of Liège, GIGA-Cancer Research, Human Genetics Unit, Liège, Belgium. · Human Genetics Department, Liège University Hospital, Liège, Belgium. · Pubmed 25880076
  • Laboratory of Molecular Angiogenesis, GIGA-R, University of Liège, Belgium. · Laboratory of Human Genetics, GIGA-R, University of Liège, Belgium. · Laboratory of Tumor & Development Biology, GIGA-R, University of Liège, Belgium. · Laboratory of Cell and Tissues Biology, University of Liège, Belgium. · Department of Medical Oncology, CHU, Liège, Belgium. · Pubmed 25860935
  • University of Liège, Laboratory of Medical Oncology, Liège, Belgium. · University of Liège, GIGA-Research, Molecular Angiogenesis Laboratory, Liège, Belgium. · University of Liège, GIGA-Research, Human Genetics, Liège, Belgium. · Pubmed 25078559
2014
  • Department of Medical Oncology, INSERM Unit U981, Université Paris Sud, Institut Gustave Roussy, Villejuif, France. · Winship Cancer Institute of Emory University, Atlanta, GA, USA. · Cerrahpasa Medical Faculty, Department of Medicine, Division of Medical Oncology, Istanbul University, Istanbul, Turkey. · Kyoto University, Sakyo-ku, Kyoto, Japan. · Department of Medical Oncology, Cancer Hospital and Institute, Chinese Academy of Medical Sciences and Peking Union Medical College, Chaoyang District, Beijing, China. · Centre Hospitalier Universitaire du Sart-Tilman, Domaine Universitaire B35, Liège, Belgium. · NHO Osaka National Hospital, Chuou-ku, Osaka, Japan. · Cancer Care Centers of South Texas, San Antonio, TX, USA. · NYU Langone Arena Oncology, Lake Success, NY, USA. · Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA. · National Cancer Centre Singapore, Singapore. · Oncology Department, Military Hospital, Budapest, Hungary. · Orszagos Onkologiai Intezet, Budapest, Hungary. · Christie Hospital NHS Foundation Trust, Manchester, UK. · Sanatorio de la Providencia, Buenos Aires, Argentina. · Monash Medical Center, Moorabbin Hospital, Bentleigh East, VIC, Australia; Cabrini Brighton Hospital, Brighton, VIC, Australia. · Comprehensive Breast Health Center, RuiJin Hospital, School of Medicine, Shanghai JiaoTong University, Shanghai, China. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Oncology Global Development, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Ospedale San Raffaele Scientific Institute, Milan, Italy. Electronic address: · Pubmed 24742739
  • Affiliations of authors: "Sandra Pitigliani" Medical Oncology Unit, Hospital of Prato, Prato, Italy (ADL, LM) · Medical Oncology, Centre Hospitalier Universitaire Sart Tilman and Liège University, Liège, Belgium (GJ) · Department of Oncology, First Faculty of Medicine of Charles University, Prague, Czech Republic (LP) · Clinical Oncology, Instituto Nacional del Cáncer, Santiago, Chile (RT) · Dnipropetrovsk Municipal Clinical Hospital, Dnipropetrovsk, Ukraine (INB) · Republican Clinical Oncological Center, Kazan, Russia (RK) · AZ Klina, Brasschaat, Belgium (DV) · Mastology, Hospital Nossa Senhora da Conceição, Porto Alegre, Brazil (JLP) · Thoracal Department, Medical Radiological Science Center, Obninsk, Russia (IS) · Chemotherapy and Combined Therapy, Russian Cancer Research Centre, Moscow, Russia (MRL) · Medical Oncology, Kansas City Cancer Center, Kansas City, MO USA (KP) · AstraZeneca Pharmaceuticals, Macclesfield, UK (SG, YR) · Medical Oncology Service, Instituto de Investigacion Sanitaria, Hospital Universitario Gregorio Maranon, Universidad Complutense, Madrid, Spain (MM). · Pubmed 24317176
  • Laboratory of Tumor and Developmental Biology, Groupe Interdisciplinaire de Génoprotéomique Appliquée-Cancer (GIGA-Cancer), University of Liège, Liège, Belgium. · Department of Medical Oncology, Centre Hospitalier Universitaire (CHU), Sart Tilman, Liège, Belgium. · Department of Pathology, University of Liège, Liège, Belgium. · Laboratory of Tumor and Developmental Biology, Groupe Interdisciplinaire de Génoprotéomique Appliquée-Cancer (GIGA-Cancer), University of Liège, Liège, Belgium. · Pubmed 25320013
  • CHU Sart Tilman, Liège, Belgium. Electronic address: · Istituti Ospitalieri di Cremona, Cremona, Italy. · Hospital Universitario 12 de Octubre, Madrid, Spain. · CHU Sart Tilman, Liège, Belgium. · Medisch Spectrum Twente, Enschede, The Netherlands. · Agendia NV, Amsterdam, The Netherlands. · Medisch Spectrum Twente, Enschede, The Netherlands; Saxenburgh Groep, Hardenberg, The Netherlands. · Pubmed 24685596
2015
  • Department of Plastic and Maxillo-facial Surgery, University Hospital, C.H.U. de Liège, Domaine Universitaire du Sart-Tilman - B. 35, 4000 Liège, Belgique. · Pubmed 26021789
2014
  • Authors' Affiliations: Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Catalan Institute of Oncology, Barcelona, Spain; Sarah Cannon Research Institute, Nashville, Tennessee; Novartis Pharmaceuticals, East Hanover, NJ; Novartis Pharmaceuticals, Florham Park, New Jersy; C.H.U. Sart-Tilman, Liege; Oncologisch Centrum AZ-St. Augustinus Oncology, Antwerp, Belgium; Novartis Pharma AG, Basel, Switzerland; Novartis Oncology, Paris, France; Memorial Sloan-Kettering Cancer Centre, New York, New York; Highlands Oncology Group, Fayetteville, Arkansas; and Novartis Institutes for BioMedical Research, Cambridge, Massachusetts. · Pubmed 24470511
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 58 total) written by Guy H. M. Jerusalem about Breast Neoplasms:

  • HER2+ breast cancer treatment and cardiotoxicity: monitoring and management. 2019
  • Real-world use of granulocyte colony-stimulating factor in ambulatory breast cancer patients: a cross-sectional study. 2019
  • Natural Antisense Transcripts: Molecular Mechanisms and Implications in Breast Cancers. 2018
  • Pharmacokinetic Effects and Safety of Olaparib Administered with Endocrine Therapy: A Phase I Study in Patients with Advanced Solid Tumours. 2018
  • Exercise and Education Program After Breast Cancer: Benefits on Quality of Life and Symptoms at 3, 6, 12, and 24 Months' Follow-up. 2018
  • Everolimus Plus Exemestane vs Everolimus or Capecitabine Monotherapy for Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer: The BOLERO-6 Randomized Clinical Trial. 2018
  • Phase III Randomized Study of Ribociclib and Fulvestrant in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: MONALEESA-3. 2018
  • First-line vs second-line fulvestrant for hormone receptor-positive advanced breast cancer: A post-hoc analysis of the CONFIRM study. 2018
  • A randomized phase II study evaluating different maintenance schedules of nab-paclitaxel in the first-line treatment of metastatic breast cancer: final results of the IBCSG 42-12/BIG 2-12 SNAP trial. 2018
  • Phase II study of buparlisib (BKM120) and trastuzumab in patients with HER2+ locally advanced or metastatic breast cancer resistant to trastuzumab-based therapy. 2018
Show List of Full Article Records
Google Searches

Learn more about Guy H. M. Jerusalem using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Universite de Liege
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Universite de Liege
2019
  • Department of Medical Oncology, Centre Hospitalier Universitaire du Sart-Tilman, University of Liege, Liège, Belgium. · GIGA Cardiovascular Sciences, Department of Cardiology, Centre Hospitalier Universitaire du Sart-Tilman, University of Liege, Liège, Belgium. · Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Korea. · Pubmed 31165940
  • AZ Glorieux, Ronse, Belgium and Gent University Hospital, Ghent, Belgium. · Gent University Hospital, De Pintelaan 185, 9000, Ghent, Belgium. · Department of Medical Oncology, Imelda Hospital, Bonheiden, Belgium. · CHU Sart Tilman Liège and University of Liège, Liège, Belgium. · OncoLogX, Antwerp, Belgium. · Amgen, Brussels, Belgium. · Gent University Hospital, De Pintelaan 185, 9000, Ghent, Belgium. · Pubmed 30099601
2018
  • Laboratory of Human Genetics, GIGA-Institute, University of Liège, 4500 Liège, Belgium. · Laboratory of Human Genetics, GIGA-Institute, University of Liège, 4500 Liège, Belgium. · Laboratory of Human Genetics, GIGA-Institute, University of Liège, 4500 Liège, Belgium. · Center of Genetics, University Hospital (CHU), 4500 Liège, Belgium. · Laboratory of Human Genetics, GIGA-Institute, University of Liège, 4500 Liège, Belgium. · Department of Medical Oncology, University Hospital (CHU), 4500 Liège, Belgium. · Laboratory of Medical Oncology, GIGA-Institute, University of Liège, 4500 Liège, Belgium. · Department of Medical Oncology, University Hospital (CHU), 4500 Liège, Belgium. · Laboratory of Medical Oncology, GIGA-Institute, University of Liège, 4500 Liège, Belgium. · Pubmed 29301303
  • Northern Centre for Cancer Care, Newcastle University, Newcastle upon Tyne, UK. · Department of Medical Oncology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands. · University Medical Center Utrecht, University of Utrecht, Utrecht, The Netherlands. · Universitair Ziekenhuis Leuven, Leuven, Belgium. · The Royal Marsden and Institute of Cancer Research, Sutton, UK. · Universitair Ziekenhuis Antwerpen, Antwerp, Belgium. · Herlev Hospital, University of Copenhagen, Herlev, Denmark. · Department of Medical Oncology, Oncologisch Centrum, Universitair Ziekenhuis Brussel, Brussels, Belgium. · Universitair Ziekenhuis Gent, Ghent, Belgium. · CHU Sart-Tilman Liege, Liege University, Liege, Belgium. · Department of Medical Oncology, Institut Bergonié, Comprehensive Cancer Centre Bordeaux, Bordeaux, France. · King's College London, Guy's Hospital, London, UK. · Campus Sint-Augustinus, GZA Ziekenhuizen, Antwerp, Belgium. · AstraZeneca, Gaithersburg, MD, USA. · AstraZeneca, Macclesfield, UK. · AstraZeneca, Cambridge, UK. · The Christie NHS Foundation Trust, University of Manchester, Manchester, UK. · Pubmed 30324586
  • Department of Sport and Rehabilitation Science, Liège University, Liège, Belgium; Department of Physical and Rehabilitation Medicine, Liège University Hospital, Liège, Belgium. Electronic address: · Department of Public Health, Epidemiology and Health Economics, Liège University, Liège, Belgium. · Division of Medical Oncology, Liège University, Liège University Hospital, Liège, Belgium. · Department of Radiotherapy, Liège University, Liège University Hospital, Liège, Belgium. · Department of Sport and Rehabilitation Science, Liège University, Liège, Belgium; Department of Physical and Rehabilitation Medicine, Liège University Hospital, Liège, Belgium. · Department of Sport and Rehabilitation Science, Liège University, Liège, Belgium. · Clinical Hematology Service, Oncology Centre, Liège University Hospital, Liège, Belgium. · Pubmed 29880408
  • CHU Sart Tilman Liege and Liege University, Liege, Belgium. · Royal Melbourne Hospital, Victoria, Australia. · Jonsson Comprehensive Cancer Center, University of California, Los Angeles. · Sarah Cannon Research Institute, Nashville, Tennessee. · Tennessee Oncology, PLLC, Nashville, Tennessee. · Russian Cancer Research Center, Moscow, Russia. · Copenhagen University Hospital, Copenhagen, Denmark. · Rainier Hematology-Oncology, Northwest Medical Specialties, Tacoma, Washington. · Cerrahpaşa School of Medicine, Istanbul University, Istanbul, Turkey. · Uzsoki Teaching Hospital, Budapest, Hungary. · Institute of Clinical Research, Odense University Hospital, University of Southern Denmark, Odense, Denmark. · Novartis Pharmaceuticals Corporation, East Hanover, New Jersey. · Novartis Pharma AG, Basel, Switzerland. · Novartis Pharma SAS, Paris, France. · Pubmed 29862411
  • Dennis J. Slamon, University of California Los Angeles Medical Center, Santa Monica, CA · Patrick Neven, Multidisciplinary Breast Centre, Universitair Ziekenhuis, Leuven · Guy Jerusalem, Centre Hospitalier Universitaire de Liege and Liege University, Liège, Belgium · Stephen Chia, British Columbia Cancer Agency, Vancouver, British Columbia, Canada · Peter A. Fasching, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen · Arnd Nusch, Practice for Hematology and Internal Oncology, Velbert, Germany · Michelino De Laurentiis, Istituto Nazionale Tumori "Fondazione G. Pascale," Naples · Giulia Val Bianchi, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale dei Tumori, Milan, Italy · Seock-Ah Im, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea · Katarina Petrakova, Masaryk Memorial Cancer Institute, Brno, Czech Republic · Francisco J. Esteva, New York University Langone Health, New York, NY · Miguel Martín, Instituto de Investigacion Sanitaria Gregorio Marañon, Centro de Investigación Biomédica en Red de Cáncer, Grupo Español de Investigación en Cáncer de Mama, Universidad Complutense, Madrid · Luis De la Cruz-Merino, Hospital Universitario Virgen Macarena, Seville, Spain · Gabe S. Sonke, Netherlands Cancer Institute/Borstkanker Onderzoek Groep Study Center, Amsterdam, the Netherlands · J. Thaddeus Beck, Highlands Oncology Group, Fayetteville, AR · Xavier Pivot, Institut Régional du Cancer, Strasbourg, France · Gena Vidam, Karen Rodriguez Lorenc, Michelle Miller, and Tetiana Taran, Novartis Pharmaceuticals, East Hanover, NJ · and Yingbo Wang, Novartis Pharma, Basel, Switzerland. · Pubmed 29860922
  • Sandro Pitigliani Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Via Suor Niccolina 20, Prato 59100, Italy. Electronic address: · CHU Sart Tilman Liège and Liège University, Avenue de L'Hôpital 1, 4000 Liège, Belgium. Electronic address: · Instituto Nacional del Cáncer, Avda Profesor Zañartu 1010, Independencia, Santiago, Región Metropolitana, Chile. Electronic address: · University of Antwerp, Prinsstraat 13, 2000 Antwerpen, Belgium. Electronic address: · University of Kansas Cancer Center, 1000 E 101st Terrace, Kansas City, MO 64131, USA. Electronic address: · Sandro Pitigliani Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Via Suor Niccolina 20, Prato 59100, Italy. Electronic address: · AstraZeneca, da Vinci Building, Melbourn Science Park, Melbourn, Royston, Herts, SG8 6HB, UK. Electronic address: · Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, CiberOnc, GEICAM, Madrid 28007, Spain. Electronic address: · Pubmed 29324303
  • Division of Medical Oncology, E.O. Ospedali Galliera, Genova, Italy. · IBCSG Statistical Center, Boston, USA. · Frontier Science and Technology Research Foundation, Boston, USA. · Breast Center, Kantonsspital St. Gallen, St. Gallen. · SAKK, Bern, Switzerland. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Department of Medical Oncology, St. James Hospital, Dublin, Ireland. · FMH Medical Oncology, Chur, Switzerland. · Department of Medical Oncology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Department of Medical Oncology, Ramon y Cajal University Hospital, Barcelona, Spain. · Breast Cancer & Melanoma Group, Hospital Universitari Vall D'Hebron, Barcelona, Spain. · Centre for Systems Medicine, Beaumont Hospital, Dublin, Ireland. · Clinical Trials, Ireland. · Oncology Research Group, Hospital Universitari Sant Joan De Reus, Tarragona, Spain. · IBCSG Coordinating Center, Bern, Switzerland. · Bern University Hospital, Inselspital, Bern, Switzerland. · Medical Oncology, Hospital Universitari Arnau De Vilanova De Lleida, Lleida, Spain. · Breast Unit, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland. · Onco-Hematology, CHPLT Verviers, Verviers, Belgium. · Institute of Oncology, Ljubljana, Slovenia. · IBCSG Statistical Center, Dana-Farber Cancer Institute, Boston, USA. · Department of Medicine, Harvard Medical School, Boston, USA. · Medical Oncology, CHU Sart Tilman, Liege, Belgium. · Pubmed 29228091
  • Breast Cancer Unit, Institut Gustave Roussy, 114 Rue Edouard-Vaillant, 94800, Villejuif, France. · Macerata Hospital, Macerata, Italy. · Saint Luke's Health System, Kansas City, MO, USA. · Onkologikoa Foundation, San Sebastian, Spain. · Catalan Institute of Oncology, Barcelona, Spain. · Ospedale Oncologico, Cagliari, Italy. · University of Birmingham and University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK. · University of Oxford and Oxford University Hospitals NHS Trust, Oxford, UK. · Centre Léon Bérard et Inserm U1052, Lyon, France. · Nottingham University Hospitals NHS Trust, Nottingham, UK. · Moffitt Cancer Center, Tampa, FL, USA. · CHU Sart Tilman Liège and University of Liège, Liège, Belgium. · Novartis Pharma AG, Basel, Switzerland. · Novartis Institutes for BioMedical Research, Cambridge, MA, USA. · Novartis Pharmaceuticals Corporation, Rueil-Malmaison, France. · Syros Pharmaceuticals, Watertown, MA, USA. · Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Pubmed 29198055
  • International Breast Cancer Study Group, Milan, Italy; Division of Medical Senology, Milan, Italy. Electronic address: · International Breast Cancer Study Group Statistical Center, Boston, MA, USA; Dana-Farber Cancer Institute, Boston, MA, USA. · International Breast Cancer Study Group and Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. · International Breast Cancer Study Group, Australia and New Zealand Breast Cancer Trials Group, and Box Hill and Maroondah Hospitals, Monash University, Melbourne, VIC, Australia. · International Breast Cancer Study Group and Lucerne Canton Hospital, Lucerne, Switzerland. · International Breast Cancer Study Group, Centre Hospitalier Universitaire de Liège, Liège University, Liège, Belgium. · International Breast Cancer Study Group and Multidisciplinary Breast Center, University Hospitals, Katholieke Universiteit Leuven, Leuven, Belgium. · International Breast Cancer Study Group and National Institute of Oncology, Budapest, Hungary. · International Breast Cancer Study Group and Centre Hospitalier Chrétien Clinique St Joseph, Liège, Belgium. · International Breast Cancer Study Group and ASST Spedali Civili di Brescia, Brescia, Italy. · Danish Breast Cancer Group and Rigshospitalet, Copenhagen, Denmark. · Scottish Cancer Trials Breast Group and The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · German Breast Group, Neu-Isenburg, Germany. · SOLTI Group and Fundación Instituto Valenciano de Oncologia, Valencia, Spain. · Japan Breast Cancer Research Group and Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan. · Austrian Breast & Colorectal Cancer Study Group and Department of Obstetrics and Gynecology, Medical University Innsbruck, Innsbruck, Austria. · Chilean Cooperative Group for Oncologic Research, Providencia, Santiago, Chile. · Cancer Trials Ireland and Cork University Hospital, Cork, Ireland. · International Breast Cancer Study Group and Centro di Riferimento Oncologico di Aviano, Aviano, Italy. · Medical Oncology Clinic, Institute Jules Bordet, Brussels, Belgium. · Swiss Group for Clinical Cancer Research, International Breast Cancer Study Group, and Breast Center St Gallen, St Gallen, Switzerland. · Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. · International Breast Cancer Study Group Coordinating Center, Bern, Switzerland. · International Breast Cancer Study Group Coordinating Center, Bern, Switzerland; Bern University Hospital, Inselspital, Bern, Switzerland. · European Institute of Oncology, Milan, Italy; International Breast Cancer Study Group Central Pathology Office and University of Milan, Milan, Italy. · International Breast Cancer Study Group, Inselspital, Bern, Switzerland; Bern University Hospital, Inselspital, Bern, Switzerland. · International Breast Cancer Study Group Statistical Center, Boston, MA, USA; Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Harvard T H Chan School of Public Health, Boston, MA, USA; Frontier Science & Technology Research Foundation, Boston, MA, USA. · International Breast Cancer Study Group and University of Sydney, Sydney, NSW, Australia. · International Breast Cancer Study Group and Hospital of Prato-AUSL Toscana Centro, Istituto Toscano Tumori, Prato, Italy. · International Breast Cancer Study Group Statistical Center, Boston, MA, USA; Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. · International Breast Cancer Study Group, Milan, Italy; European Institute of Oncology, Milan, Italy. · Pubmed 29158011
  • Sint Augustinus-University of Antwerp, Antwerp, Belgium. · Semmelweis University, Budapest, Hungary. · CHU Sart Tilman Liege and Liege University, Liege, Belgium. · University Cancer & Blood Center, LLC, Athens, GA, USA. · Sarah Cannon Research Institute, London, UK. · University College London Cancer Institute, London, UK. · University of Alabama, Birmingham, AL, USA. · Center for Cancer and Blood Disorders, Bethesda, MD, USA. · University of Miami Miller School of Medicine, Miami, FL, USA. · Cooper Hospital University Medical Center, Camden, NJ, USA. · Nemocnice Horovice, Onkologicke Oddelení, Horovice, Czech Republic. · The John Hopkins University School of Medicine, Baltimore, MD, USA. · Michigan State University, East Lansing, MI, USA. · Greenville Hospital System, Greenville, SC, USA. · Metairie Oncologist LLC, Metairie, LA, USA. · Merck KGaA, Darmstadt, Germany. · EMD Serono, Billerica, MA, USA. · Sarah Cannon Research Institute, Nashville, TN, USA. · Pubmed 29063313
  • Public Health Department and Sensation and Perception Research Group, GIGA-Consciousness, University of Liège, Liège, Belgium. · Algology-Palliative Care Department, CHU Liège, and Sensation and Perception Research Group, GIGA-Consciousness, University of Liège, Liège, Belgium. · GIGA-Consciousness, Coma Science Group & Neurology Department, University and CHU of Liège, Liège, Belgium. · Medical Oncology Department, CHU Liège and University of Liège, Liège, Belgium. · Public Health Department and Sensation and Perception Research Group, GIGA-Consciousness, University of Liège, Liège, Belgium. · Pubmed 30442120
  • Department of Medical Oncology, University Hospital (CHU) and University of Liège, Liège, Belgium. · Laboratory of Human Genetics, GIGA Research, University Hospital (CHU) and University of Liège, Liège, Belgium. · GIGA Cardiovascular Sciences, Department of Cardiology, Heart Valve Clinic, University Hospital (CHU) and University of Liège, Liège, Belgium. · Gruppo Villa Maria Care and Research, Anthea Hospital, Bari, Italy. · Department of Medical Oncology, University Hospital (CHU) and University of Liège, Liège, Belgium. · Pubmed 29378531
2017
  • Health Psychology Department, University of Liege, Liege 4000, Belgium. · Public Health Department, University of Liege, Liege 4000, Belgium. · Medical Oncology Department, CHU Liege, Liege 4000, Belgium. · Radiation Oncology Department, CHU Liege, University of Liege, Liege 4000, Belgium. · Psychology Department, University of Quebec at Montreal, Montreal, QC H2L 2C4, Canada. · Algology-Palliative Care Department, CHU Liege, University of Liege, Liege 4000, Belgium. · Pubmed 28926526
  • a University of Liege , Liege , Wallonia , Belgium. · b University of Quebec at Montreal , Montreal , Quebec , Canada. · Pubmed 28230462
  • University of Liège, GIGA-Research, Laboratory of Human Genetics, Liege, Belgium. · University Hospital (CHU), Department of Medical Oncology, Liege, Belgium. · University Hospital (CHU), Center of Genetics, Liege, Belgium. · University of Liège, GIGA-Genomics Platform, Liege, Belgium. · Clinique Saint-Vincent (CHC), Department of Pathology, Liege, Belgium. · University of Liège, GIGA-Research, Laboratory of Human Genetics, Liege, Belgium. · University Hospital (CHU), Department of Medical Oncology, Liege, Belgium. · Pubmed 29234122
  • Psychology of Aging Unit, Department of Psychology, University of Liège (ULg), Traverse des Architectes (B63c), 4000, Liege, BE, Belgium. · INSERM U12919 Bordeaux Population Health, University of Bordeaux, Bordeaux, France. · Psychology of Aging Unit, Department of Psychology, University of Liège (ULg), Traverse des Architectes (B63c), 4000, Liege, BE, Belgium. · Laboratory of Medical Oncology, University of Liège, Liège, Belgium. · Department of Medical Oncology, CHU Sart-Tilman Liège, Liège, Belgium. · Department of General Practice, KU Leuven, Leuven, Belgium. · CAPHRI Research School, Maastricht University, Maastricht, The Netherlands. · Pubmed 28865449
  • Department of Sport and Rehabilitation Science, Liège University, Liège, Belgium - · Department of Physical Medicine, Liège University Hospital, Liège, Belgium - · Department of Sport and Rehabilitation Science, Liège University, Liège, Belgium. · Department of Physical Medicine, Liège University Hospital, Liège, Belgium. · Department of Radiotherapy, Liège University, Liège University Hospital, Liège, Belgium. · Clinical Hematology Service, Oncology Center, Liège University Hospital, Liège, Belgium. · Department of Public Health, Epidemiology and Health Economics, Liège University, Liège, Belgium. · Division of Medical Oncology, Liège University, Liège University Hospital, Liège, Belgium. · Department of Senology, Liège University Hospital, Liège, Belgium. · Pubmed 28322035
  • Laboratory of Tumor and Developmental Biology, Groupe Interdisciplinaire de Génoprotéomique Appliqué-Cancer (GIGA-Cancer), University of Liège, Liège 4000, Belgium. · Department of Medical Oncology, University Hospital of Liège (CHU), Liège 4000, Belgium. · Faculty of Medicine, University of Liège, Liège 4000, Belgium. · Laboratory of Experimental Pathology, GIGA-Cancer, University of Liège, Liège 4000, Belgium. · Biobank (Biothèque Universitaire de Liège), University of Liège, Liège 4000, Belgium. · Department of Biostatistics, University of Liège, 4000 Liège, Belgium. · Pubmed 28196064
  • Psychology of Aging Unit, University of Liège, Liège, Belgium. Electronic address: · Psychology of Aging Unit, University of Liège, Liège, Belgium. · Laboratory of medical oncology, University of Liège, Liège, Belgium; Department of Medical Oncology, CHU Sart-Tilman Liège, Liège, Belgium. · Department of Social Psychology, University of Liège, Liège, Belgium. · Department of General Practice, KU Leuven, Leuven, Belgium; CAPHRI Research School, Maastricht University, Maastricht, The Netherlands. · Pubmed 27659547
2016
  • Department of Medical Oncology, CHU Sart Tilman Liege and Liege University, Domaine Universitaire du Sart Tilman, Liege, Belgium · Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy. · Medical Oncology Department, Breast Cancer Unit, University Hospital 12 de Octubre, Madrid, Spain. · Instituto de Investigación Sanitaria Gregorio Marañón, Univesidad Complutense, Madrid, Spain. · Department of Medical Oncology, GROW, Maastricht University Medical Centre, Maastricht, The Netherlands. · KULeuven (University of Leuven), Department of Oncology, Multidisciplinary Breast Center, University Hospitals Leuven, Belgium. · Medical Oncology Unit of Fundacion Instituto Valenciano De Oncologia, Valencia, Spain. · UO Oncologia Medica I, Azienda Ospedaliera Universitaria Pisana, Santa Chiara Hospital, Pisa, Italy. · Unit of Investigative Clinical Oncology (INCO), Fondazione del Piemonte per l'Oncologia, Institute of Candiolo Cancer Center (IRCCs), Candiolo, Torino, Italy. · Department of Medical, Surgery and Health Sciences, University of Trieste, Trieste, Italy. · Breast Unit, Azienda Ospedaliera Spedali Civili, Brescia, Italy. · Medical Oncology and Clinical Pharmacology, National Institute of Oncology, Budapest, Hungary. · Narodny Onkologicky Ustav Klenova 1, Bratislava, Slovakia. · Department of Oncology, Oslo University Hospital, Oslo, Norway K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. · Novartis Farma S.p.A., Origgio, VA, Italy. · Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy Medical Oncology 2, Istituto Oncologico Veneto, Padova, Italy. · Pubmed 27358383
  • Fabrice André, Institut Gustav Roussy, INSERM Unit U981, Université Paris Sud, Villejuif, France · Sara Hurvitz and Dennis Slamon, University of California, Los Angeles, Los Angeles, CA · Angelica Fasolo, San Raffaele Scientific Institute, Milan, Italy · Ling-Ming Tseng, National Yang Ming University, Taipei, Taiwan · Guy Jerusalem, University of Liège, Liege, Belgium · Sharon Wilks, Cancer Care Center of South Texas, San Antonio, TX · Ruth O'Regan, University of Wisconsin Carbone Cancer Center, Madison, WI · Claudine Isaacs, Georgetown University, Washington DC · Masakazu Toi, Kyoto University, Sakyo-ku, Kyoto, Japan · Howard Burris, Sarah Cannon Research Institute, Nashville, TN · Wei He, Douglas Robinson, and Markus Riester, Novartis Institutes for BioMedical Research, Cambridge, MA · and Tetiana Taran and David Chen, Novartis Pharmaceuticals Corporation, East Hanover, NJ. · Pubmed 27091708
  • GIGA-Cancer, Laboratory of Tumor and Development Biology, University of Liège, Liège, Belgium. · CHU, Department of Medical Oncology, University of Liège, Liège, Belgium. · GIGA-Cardiovascular Sciences, Laboratory of Thrombosis and Hemostasis, University of Liège, Liège, Belgium. · Unit of Molecular and Cellular Oncology Lab, Inflammation Research Center, VIB, Ghent, Belgium. Department of Biomedical Molecular Biology, Cancer Research Institute Ghent (CRIG), Ghent University, Ghent, Belgium. · Institute of Health and Biomedical Innovation and School of Biomedical Sciences Translational Research Institute, Queensland University of Technology, Brisbane, Australia. · GIGA-Neurosciences, Unit of Cell and Tissue Biology, University of Liège, Liège, Belgium. · Australian Prostate Cancer Research Centre - Queensland, Institute of Health and Biomedical Innovation, School of Biomedical Sciences, Queensland University of Technology, Princess Alexandra Hospital, Translational Research Institute, Brisbane, Australia. · INSERM UMR-S 903, CHU, Biopathology Laboratory, University of Reims, Reims, France. · GIGA-Cancer, Laboratory of Tumor and Development Biology, University of Liège, Liège, Belgium. · Pubmed 27221703
  • University Hospital (CHU), Department of Medical Oncology, Liège, Belgium. · University of Liège, GIGA-Research, Laboratory of Human Genetics, Liège, Belgium. · University of Liège, GIGA-Research, Laboratory of Molecular Angiogenesis, Liège, Belgium. · University of Liège, GIGA-Research, Department of EE and CS, Liège, Belgium. · University Hospital (CHU), Department of Gynecology, Liège, Belgium. · University Hospital (CHU), Department of Senology, Liège, Belgium. · Clinique Saint-Vincent (CHC), Department of Pathology, Liège, Belgium. · Pubmed 26734993
  • Psychology of Aging Unit,University of Liège (B63C),Liège,Belgium. · Laboratory of Medical Oncology,University of Liège,Liège,Belgium. · Department of Nursing,CHU Sart-Tilman Liège,Liège,Belgium. · Pubmed 26669734
2015
  • Medical Oncology, CHU Sart Tilman Liege & Liege University, Domaine Universitaire du Sart Tilman, B35, 4000 Liege, Belgium. · University of Liège Hospital, GIGA Cardiovascular Sciences, Cardio-Oncology Clinic Unit, CHU Sart Tilman Liege & Liege University, Domaine Universitaire du Sart Tilman, B35, 4000 Liege, Belgium. · Pubmed 26344798
  • Medical Oncology CHU Sart Tilman Liege & Liege University, Domaine Universitaire du Sart Tilman, B35, 4000 Liege, Belgium. · Medical Oncology CHU Sart Tilman Liege, Domaine Universitaire du Sart Tilman, B35, 4000 Liege, Belgium. · Pubmed 26075446
  • University of Liège Hospital, GIGA Cardiovascular Science, Heart Valve Clinic, Imaging Cardiology, Belgium and GVM Care and Research, E.S. Health Science Foundation, Lugo (RA), Italy · Department of Innovative Clinical Trials, University Medical Center Göttingen (UMG), Göttingen, Germany. · Cardiologie, CHU Rennes and LTSI-INSERM U 1099, Université Rennes 1, Rennes, France. · Department of Cardiology, Oslo University Hospital, Rikshospitalet and University of Oslo, Oslo, Norway Centre of Cardiological Innovation, Oslo, Norway. · University of Medicine and Pharmacy 'Carol Davila'-Euroecolab, 'Prof. Dr C. C. Iliescu' Institute of Cardiovascular Diseases, Bucharest, Romania. · Heart Failure Unit, Department of Cardiology, University Hospital 'Attikon', Athens, Greece. · Aix-Marseille Université, Marseille 13284, France Department of Cardiology, La Timone Hospital, 13005 Marseille, France. · ANMCO Research Center, Florence, Italy EORP Team, European Society of Cardiology, Sophia Antipolis, France. · Medical Oncology, CHU Sart Tilman Liege and Liege University, Liege, Belgium. · Department of Advanced Biomedical Sciences, Federico II University Hospital, Naples, Italy. · Pubmed 25744342
  • Centre Hospitalier Universitaire du Sart Tilman Liège and Liège University, Domaine Universitaire du Sart Tilman, B35, 4000 Liège, Belgium. Electronic address: · Centre de Recherche en Cancérologie de Lyon, Inserm U1052 CNRS 5286, Centre Léon Bérard, 28 rue Laënnec, 69373 LYON cedex 08, Lyon, France. Electronic address: · PUCRS School of Medicine, Padre Chagas 66, 203, Porto Alegre, RS 90 570 080, Brazil. Electronic address: · University Hospitals Leuven, Leuven, Belgium. Electronic address: · Hospital of Prato, Istituto Toscani Tumori, Prato, Italy. Electronic address: · Women's Hospital, University of Ulm, Prittwitzstr. 43, D-89075 Ulm, Germany. Electronic address: · Royal Melbourne Hospital, Grattan St., Parkville, Melbourne 3050, Australia. Electronic address: · Pubmed 25575443
  • Institut Curie, Paris, France. Electronic address: · University Hospital Leuven, Leuven, Belgium. Electronic address: · Medical University of Gdańsk, Gdańsk, Poland. Electronic address: · General Hospital Sint-Augustinus, Antwerp, Belgium. Electronic address: · Centre Léon Bérard, Lyon, France. Electronic address: · Helsinki University Central Hospital, Helsinki, Finland. Electronic address: · UCLA School of Medicine, Los Angeles, CA, USA. Electronic address: · Institut Paoli-Calmettes, Marseilles, France. Electronic address: · C.R.L.C. Val D'Aurelle, Montpellier, France. Electronic address: · Levine Cancer Institute, Charlotte, NC, USA. Electronic address: · CHU Sart Tilman, Liege, Belgium. Electronic address: · Kidwai Memorial Institute of Oncology, Bangalore, India. Electronic address: · Institut Claudius Régaud, Toulouse, France. Electronic address: · Complejo Hospitalario de Jaén, Jaén, Spain. Electronic address: · European Health Centre Otwock, Warszawa, Poland. Electronic address: · Corporació Sanitària Parc Taulí, Sabadell, Spain. Electronic address: · Amgen Inc., Thousand Oaks, CA, USA. Electronic address: · Amgen Inc., Thousand Oaks, CA, USA. Electronic address: · Amgen Inc., Thousand Oaks, CA, USA. Electronic address: · UCLA School of Medicine, Los Angeles, CA, USA. Electronic address: · Pubmed 25747197
  • Department of Medical Oncology, Institut Bergonié Comprehensive Cancer Centre, Université de Bordeaux, INSERM U916, Bordeaux · Department of Medical Oncology, Centre Val D'Aurelle-Paul Lamarque, Montpellier. · Department of Medical Oncology, Gustave Roussy, Villejuif. · Department of Medical Oncology, Centre Henri Becquerel, Rouen. · Department of Medical Oncology, Centre Hospitalier Universitaire, Limoges, France. · Department of Oncology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland. · Department of Medical Oncology, Institute of Oncology, Ljubljana, Ljubljana University Clinic, Golnik, Slovenia. · Department of Medical Oncology, Centre Paul Strauss, Strasbourg, France. · Gyneco-Oncology Unit, Hôpitaux Universitaires de Genève (HUG), Geneva, Switzerland. · Department of Medical Oncology, Institut Bergonié Comprehensive Cancer Centre, Université de Bordeaux, INSERM U916, Bordeaux. · Department of Medical Oncology, Hôpital St Elisabeth, Namur. · Department of Medical Oncology, Centre Hospitalier Universitaire (Sart Tilman), Liege, Belgium. · Medical Oncology and Clinical Research Unit, Ensemble Hospitalier de L'Institut Curie, Hôpital René Huguenin, St-Cloud. · Department of Medical Oncology, Centre Léon Bérard, Lyon, France. · Department of Statistics, European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium. · Edinburgh Breast Unit and Edinburgh University Cancer Research Centre, Western General Hospital, Edinburgh, UK. · Pubmed 25467016
  • a Department of Plastic and Maxillo-facial Surgery, University Hospital , Belgique. · b Department of Abdominal, Breast and Endocrine Surgery and Transplantation , Belgique. · c Department of Senology , Belgique. · d Department of Anatomo-pathology , Belgique. · e Department of Biostatistics, SIME ; Belgique . · f Department of Radiotherapy , Belgique. · g Department of Medical Oncology , University Hospital, C.H.U. de Liege, Domaine Universitaire du Sart-Tilman - B. 35 , 4000 Liege, Belgique. · Pubmed 27384894
  • Centre Hospitalier Universitaire Sart Tilman Liège and Liège University, Domaine Universitaire du Sart Tilman, B35, 4000, Liège, Belgium. · University Hospitals Leuven, Herestraat 49, box 7003, B-3000, Leuven, Belgium. · Navigant Consulting, Inc, Woolgate Exchange, 25 Basinghall Street, EC2V 5HA, London, UK. · Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, NJ, 07936-1080, USA. · Navigant Consulting, Inc, Woolgate Exchange, 25 Basinghall Street, EC2V 5HA, London, UK. · Novartis Farma S.p.A., Largo Umberto Boccioni 1, I-21040, Origgio, VA, Italy. · Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, NJ, 07936-1080, USA. · Wellmera AG, Basel, Switzerland. · Institut Gustave Roussy, 39 Rue C. Desmoulins, 94805, Villejuif, France. · Pubmed 26498283
  • Human Genetics Unit, GIGA-Cancer Research, University of Liège, Liège, Belgium. · Human Genetics Unit, GIGA-Cancer Research, University of Liège, Liège, Belgium. · Human Genetics Unit, GIGA-Cancer Research, University of Liège, Liège, Belgium. · Human Genetics Unit, GIGA-Cancer Research, University of Liège, Liège, Belgium. · Human Genetics Unit, GIGA-Cancer Research, University of Liège, Liège, Belgium. · Medical Oncology Department, University of Liège and CHU de Liège, Liège, Belgium. · GIGA-bioinformatics platform, University of Liège, Liège, Belgium. · Human Genetics Unit, GIGA-Cancer Research, University of Liège, Liège, Belgium. · Medical Oncology Department, University of Liège and CHU de Liège, Liège, Belgium. · Center of Genetics, CHU de Liège, Liège, Belgium. · Medical Oncology Department, University of Liège and CHU de Liège, Liège, Belgium. · Medical Oncology Department, University of Liège and CHU de Liège, Liège, Belgium. · Human Genetics Unit, GIGA-Cancer Research, University of Liège, Liège, Belgium. · Center of Genetics, CHU de Liège, Liège, Belgium. · Pubmed 26490435
  • Metastasis Research Laboratory, GIGA-Cancer, University of Liège, Liège, Belgium. · Department of Pathology, University Hospital Liège, University of Liège, Liège, Belgium. · Biotheque, University of Liège, Liège, Belgium. · Animal Facility, GIGA-Cardiovascular Sciences, University of Liège, Liège, Belgium. · Metastasis Research Laboratory, GIGA-Cancer, University of Liège, Liège, Belgium; Department of Pharmacy and Health and Nutritional Sciences, University of Calabria, Arcavacata di Rende, Cosenza, Italy. · GIGA-Viral Vectors Platform, University of Liège, Liège, Belgium. · Department of Senology, University Hospital Liège, University of Liège, Liège, Belgium. · Department of Abdominal Surgery, University of Liège, Liège, Belgium. · Department of Medical Oncology, University Hospital Liège, University of Liège, Liège, Belgium. · Pubmed 26327350
  • U.O. di Patologia Mammaria-Breast Cancer Unit, U.S. Terapia Molecolare e Farmacogenomica, AO-Istituti Ospitalieri di Cremona, Viale Concordia 1, 26100, Cremona, Italy. · Centre for Research on Health and Social Care Management (CeRGAS), Bocconi University, Via Roentgen 1, Milan, Italy. · Yale Cancer Center, Yale School of Medicine, New Haven, CT, United States. · Translational Breast Cancer Genomics and Therapeutics Lab, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Centre Hospitalier Universitaire du Sart Tilman Liege and Liege University, Liège, Belgium. · U.O. di Patologia Mammaria-Breast Cancer Unit, U.S. Terapia Molecolare e Farmacogenomica, AO-Istituti Ospitalieri di Cremona, Viale Concordia 1, 26100, Cremona, Italy. · Department of Policy Analysis and Public Management, Bocconi University, Via Roentgen 1, Milan, Italy. · Pubmed 26044370
  • University of Liège, GIGA-Cancer Research, Human Genetics Unit, Liège, Belgium. · University of Liège, GIGA-Cancer Research, Human Genetics Unit, Liège, Belgium. · Division of Medical Oncology, Liège University and CHU Sart Tilman Liège, Liège, Belgium. · Human Genetics Department, Liège University Hospital, Liège, Belgium. · University of Liège, GIGA-Cancer Research, Human Genetics Unit, Liège, Belgium. · Division of Medical Oncology, Liège University and CHU Sart Tilman Liège, Liège, Belgium. · Division of Medical Oncology, Liège University and CHU Sart Tilman Liège, Liège, Belgium. · University of Liège, GIGA-Cancer Research, Human Genetics Unit, Liège, Belgium. · Human Genetics Department, Liège University Hospital, Liège, Belgium. · Pubmed 25880076
  • Laboratory of Molecular Angiogenesis, GIGA-R, University of Liège, Belgium. · Laboratory of Human Genetics, GIGA-R, University of Liège, Belgium. · Laboratory of Tumor & Development Biology, GIGA-R, University of Liège, Belgium. · Laboratory of Cell and Tissues Biology, University of Liège, Belgium. · Department of Medical Oncology, CHU, Liège, Belgium. · Pubmed 25860935
  • University of Liège, Laboratory of Medical Oncology, Liège, Belgium. · University of Liège, GIGA-Research, Molecular Angiogenesis Laboratory, Liège, Belgium. · University of Liège, GIGA-Research, Human Genetics, Liège, Belgium. · Pubmed 25078559
2014
  • Department of Medical Oncology, INSERM Unit U981, Université Paris Sud, Institut Gustave Roussy, Villejuif, France. · Winship Cancer Institute of Emory University, Atlanta, GA, USA. · Cerrahpasa Medical Faculty, Department of Medicine, Division of Medical Oncology, Istanbul University, Istanbul, Turkey. · Kyoto University, Sakyo-ku, Kyoto, Japan. · Department of Medical Oncology, Cancer Hospital and Institute, Chinese Academy of Medical Sciences and Peking Union Medical College, Chaoyang District, Beijing, China. · Centre Hospitalier Universitaire du Sart-Tilman, Domaine Universitaire B35, Liège, Belgium. · NHO Osaka National Hospital, Chuou-ku, Osaka, Japan. · Cancer Care Centers of South Texas, San Antonio, TX, USA. · NYU Langone Arena Oncology, Lake Success, NY, USA. · Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA. · National Cancer Centre Singapore, Singapore. · Oncology Department, Military Hospital, Budapest, Hungary. · Orszagos Onkologiai Intezet, Budapest, Hungary. · Christie Hospital NHS Foundation Trust, Manchester, UK. · Sanatorio de la Providencia, Buenos Aires, Argentina. · Monash Medical Center, Moorabbin Hospital, Bentleigh East, VIC, Australia; Cabrini Brighton Hospital, Brighton, VIC, Australia. · Comprehensive Breast Health Center, RuiJin Hospital, School of Medicine, Shanghai JiaoTong University, Shanghai, China. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Oncology Global Development, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Ospedale San Raffaele Scientific Institute, Milan, Italy. Electronic address: · Pubmed 24742739
  • Affiliations of authors: "Sandra Pitigliani" Medical Oncology Unit, Hospital of Prato, Prato, Italy (ADL, LM) · Medical Oncology, Centre Hospitalier Universitaire Sart Tilman and Liège University, Liège, Belgium (GJ) · Department of Oncology, First Faculty of Medicine of Charles University, Prague, Czech Republic (LP) · Clinical Oncology, Instituto Nacional del Cáncer, Santiago, Chile (RT) · Dnipropetrovsk Municipal Clinical Hospital, Dnipropetrovsk, Ukraine (INB) · Republican Clinical Oncological Center, Kazan, Russia (RK) · AZ Klina, Brasschaat, Belgium (DV) · Mastology, Hospital Nossa Senhora da Conceição, Porto Alegre, Brazil (JLP) · Thoracal Department, Medical Radiological Science Center, Obninsk, Russia (IS) · Chemotherapy and Combined Therapy, Russian Cancer Research Centre, Moscow, Russia (MRL) · Medical Oncology, Kansas City Cancer Center, Kansas City, MO USA (KP) · AstraZeneca Pharmaceuticals, Macclesfield, UK (SG, YR) · Medical Oncology Service, Instituto de Investigacion Sanitaria, Hospital Universitario Gregorio Maranon, Universidad Complutense, Madrid, Spain (MM). · Pubmed 24317176
  • Laboratory of Tumor and Developmental Biology, Groupe Interdisciplinaire de Génoprotéomique Appliquée-Cancer (GIGA-Cancer), University of Liège, Liège, Belgium. · Department of Medical Oncology, Centre Hospitalier Universitaire (CHU), Sart Tilman, Liège, Belgium. · Department of Pathology, University of Liège, Liège, Belgium. · Laboratory of Tumor and Developmental Biology, Groupe Interdisciplinaire de Génoprotéomique Appliquée-Cancer (GIGA-Cancer), University of Liège, Liège, Belgium. · Pubmed 25320013
  • CHU Sart Tilman, Liège, Belgium. Electronic address: · Istituti Ospitalieri di Cremona, Cremona, Italy. · Hospital Universitario 12 de Octubre, Madrid, Spain. · CHU Sart Tilman, Liège, Belgium. · Medisch Spectrum Twente, Enschede, The Netherlands. · Agendia NV, Amsterdam, The Netherlands. · Medisch Spectrum Twente, Enschede, The Netherlands; Saxenburgh Groep, Hardenberg, The Netherlands. · Pubmed 24685596
2015
  • Department of Plastic and Maxillo-facial Surgery, University Hospital, C.H.U. de Liège, Domaine Universitaire du Sart-Tilman - B. 35, 4000 Liège, Belgique. · Pubmed 26021789
2014
  • Authors' Affiliations: Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Catalan Institute of Oncology, Barcelona, Spain; Sarah Cannon Research Institute, Nashville, Tennessee; Novartis Pharmaceuticals, East Hanover, NJ; Novartis Pharmaceuticals, Florham Park, New Jersy; C.H.U. Sart-Tilman, Liege; Oncologisch Centrum AZ-St. Augustinus Oncology, Antwerp, Belgium; Novartis Pharma AG, Basel, Switzerland; Novartis Oncology, Paris, France; Memorial Sloan-Kettering Cancer Centre, New York, New York; Highlands Oncology Group, Fayetteville, Arkansas; and Novartis Institutes for BioMedical Research, Cambridge, Massachusetts. · Pubmed 24470511
18 Other Locations Show
Yearly article counts 21285171130000
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.